Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in PLoS Genet Retrieve available abstracts of 14 articles: HTML format

Single Articles

February 2024
1. SCOTT TG, Sathyan KM, Gioeli D, Guertin MJ, et al
   TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells.
   PLoS Genet. 2024;20:e1011159.
   PubMed     Abstract available
   
   
   November 2023
2. CARPENTER MA, Temiz NA, Ibrahim MA, Jarvis MC, et al
   Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
   PLoS Genet. 2023;19:e1011043.
   PubMed     Abstract available
   
   
   September 2023
3. WANG J, Chen Y, Zou Q
   Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model.
   PLoS Genet. 2023;19:e1010942.
   PubMed     Abstract available
   
   
   
4. SAHU S, Sullivan TL, Mitrophanov AY, Galloux M, et al
   Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
   PLoS Genet. 2023;19:e1010940.
   PubMed     Abstract available
   
   
   August 2023
5. KUMPULA TA, Vorimo S, Mattila TT, O'Gorman L, et al
   Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility.
   PLoS Genet. 2023;19:e1010889.
   PubMed     Abstract available
   
   
   
6. DIABATE M, Islam MM, Nagy G, Banerjee T, et al
   DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
   PLoS Genet. 2023;19:e1010739.
   PubMed     Abstract available
   
   
   July 2023
7. LIU W, Deng W, Chen M, Dong Z, et al
   A statistical framework to identify cell types whose genetically regulated proportions are associated with complex diseases.
   PLoS Genet. 2023;19:e1010825.
   PubMed     Abstract available
   
   
   January 2023
8. FERRANDO L, Vingiani A, Garuti A, Vernieri C, et al
   ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).
   PLoS Genet. 2023;19:e1010563.
   PubMed     Abstract available
   
   
   September 2022
9. LUONG TT, Li Z, Priedigkeit N, Parker PS, et al
   Hrq1/RECQL4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.
   PLoS Genet. 2022;18:e1010122.
   PubMed     Abstract available
   
   
   June 2022
10. SANCHEZ VC, Yang HH, Craig-Lucas A, Dubois W, et al
    Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence.
    PLoS Genet. 2022;18:e1010271.
    PubMed     Abstract available
    
    
    January 2022
11. HAYES BL, Robinson T, Kar S, Ruth KS, et al
    Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.
    PLoS Genet. 2022;18:e1009887.
    PubMed     Abstract available
    
    
    December 2021
12. GUILLON J, Coquelet H, Leman G, Toutain B, et al
    tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR.
    PLoS Genet. 2021;17:e1009953.
    PubMed     Abstract available
    
    
    November 2021
13. MADSEN RR, Erickson EC, Rueda OM, Robin X, et al
    Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype.
    PLoS Genet. 2021;17:e1009876.
    PubMed     Abstract available
    
    
    September 2021
14. FRITSCHE LG, Ma Y, Zhang D, Salvatore M, et al
    On cross-ancestry cancer polygenic risk scores.
    PLoS Genet. 2021;17:e1009670.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.